MedPath

Development of the new diagnostic method of resection stump and lymph node metastases in gastric cancer patients using 5-ALA.

Not Applicable
Conditions
gastric cancer
Registration Number
JPRN-UMIN000018548
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Porphyria Patients with a history of hypersensitivity of 5-ALA or porphyrins Patients taking drugs that may cause photosensitivity (tetracycline antibiotics, sulfonamide-based formulation, new quinolone antibiotics, hypericin, St. John's wort-containing foods, etc) Patients who is or might be pregnant Patients who is determined inappropriate to participate in the study by the attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of lymph node metastasis using fluorescence diagnostics
Secondary Outcome Measures
NameTimeMethod
The comparison to the difference in fluorescence between normal and metastatic lymph nodes, Positive predictive value, Negative predictive value
© Copyright 2025. All Rights Reserved by MedPath